Sunday, February 16, 2020 10:41:03 AM
There is NO doubt the science is real, the treated patients have often times been problematic patients and CaverStem was the first thing that has worked for them. Meds were not working, surgery was not an option. Stem cell research is showing that it may be a fix for many human ailments. There is no stopping that fact.
Imagine if StemSpine has the same success for the patients as CaverStem has started out as? A simple injection for DDD vs surgery or opioids for the pain relief, and a high percentage of success, proven by trials and research?
Will they be commercially successful and financially successful for investors? Who knows, but it’s all just starting. There are only a handful of locations you can get CaverStem and FemCelz, and they are still vastly unknown. The proof was just published last month, give it some time. StemSpine is totally unknown to the public. Papers are being completed and the evidence will be out soon. Give it some time.
Like PhD said, in hindsight, many of us invested too early, jumped on the OTC train and could have traded differently, but at that time, everyone thought it would progress faster than it did. Anyone could argue CMTH made mistakes along the way as well, but that doesn’t change the fact that they have incredible IP and will likely prevail. The company has been working on this since 2011. They are on their timeline, not ours who are trying to make a quick buck in the OTC.
Like I said many times in the past, look back at laser eye surgery. Everyone was afraid of something new. Afraid to let someone laser your eye when you could just wear glasses or contacts. It was not covered by insurance and cost a couple thousand dollars. It will never take off. Too risky, too unproven, too expensive.
How did that work out? This will follow the same path and will become commonplace. I am betting CMTH will be part of that.
Recent CELZ News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM